Medline  by unknown
terminus, were recognized by the
antibody (Fig. 1a, lane 3).
Fluorescence from the beads was
easily detectable by fluorescence
photomicroscopy when the amount of
translation reaction added to an
immunoprecipitation corresponded to
as little as 1 nl per bead (Fig. 1c). This
is equivalent to about 2 × 106 protein
molecules per bead, giving a surface
density of about 80 molecules per
mm2. Even a density as low as about 8
molecules per mm2 could be seen in
the microscope (data not shown). The
true density of fluorescent molecules
may be even lower than indicated, as
the fraction of synthesized molecules
that adopted a fluorescent
conformation is not known. Each bead
is somewhat larger than a eukaryotic
cell (90 mm in diameter), suggesting
that a similarly small number of GFP-
fusion molecules could be detected in
a living cell, particularly if the protein
were localized; autofluorescence from
a cell, however, might place a lower
limit on this number [3].
Cell-free expression of GFP seems
ideal for the rapid development of
new GFP mutants with brighter
fluorescence or shifted spectra, based
on the recently determined crystal
structure [4,5]. Large numbers of
mutants could be screened rapidly by
using cell-free coupled
transcription–translation of cDNA
clones in microtiter plates. In addition,
the fusion of GFP to other proteins
provides a simple nonradioactive
method of measuring translation
efficiency, which could expedite the
optimization of translation of any
protein of interest. Furthermore, if
radiolabeled amino acids are
incorporated, fluorescence intensity
can be correlated with protein
quantity, allowing the determination
of the density of GFP-fusion protein
molecules in a microscopic image of a
living cell, a task which cannot easily
be accomplished by analysis in vivo.
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Medline
What is it famous for? In North
America, at least, it is the usual source
of bibliographic information for
biomedical scientists. They expect
the titles and abstracts of papers in
any worthy journal to be included in
Medline in a timely fashion.
What should it be infamous for? The
fact that there are still large gaps in
its coverage of the 1996 literature,
but that few people realize this. The
problem arose because of a labour
dispute a year ago, which stopped
data entry for so long that the
backlog has still not been cleared. In
many cases (this journal included),
issues from the middle of 1996 are
missing, whereas issues from the
beginning and end of the year are
included; exactly what you find at
any time depends on who is
providing you with Medline.
What does it cover? Medline and its
printed counterpart, Index Medicus,
contain the citation information and
author abstracts from about 3800 of
the estimated 14 000 biomedical
journals that are published worldwide.
This information is supplemented by
‘MeSH’ terms, a system of key words
that are helpful for searching, and
other indexing information.
How are the journals chosen? By the
US National Library of Medicine,
which runs Medline, with the advice
of a committee that meets three
times a year and considers new or
resubmitted titles, giving them
scores of between 0 and 5. Those
that score more than 4 (about 20%)
are accepted. Journals scoring 2–4
cannot be reconsidered for two
years, and a score below 2
necessitates a four-year wait before
resubmission.
How is the information gathered?
With few exceptions, the citation
information and the abstracts from
the journals are re-keyed by Medline
staff. They also have to select and
enter the MeSH terms. The
combination of these two processes
has always resulted in a considerable
lag before an issue of a journal is
covered by Medline, although some
journals are put on a ‘fast track’.
What is happening about the lag?
Labour problems apart, re-keying has
always incurred delay. To get around
this, the National Center for
Biotechnology Information at the
National Library of Medicine has
been given the task of developing
ways of handling electronic files
supplied by publishers. Its PubMed
project (http://www4.ncbi.nlm.nih.gov/
PubMed) now contains the entire
Medline database, together with
‘PreMedline’ records, which consist of
citation information and abstracts
before MeSH and other indexing
terms have been added. When
publishers have supplied this
information in the correct electronic
format, it can appear in PubMed with
next to no delay. Moreover, PubMed
provides links from each paper to the
full text online, where it is available.
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